Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Joseph N Blattman

Joseph N Blattman

Joseph N Blattman has completed his PhD in Immunology and Molecular Pathogenesis from Emory University and Postdoctoral studies at the University of Washington and Fred Hutchinson Cancer Research Center.

Title: A quantitative understanding of the balance between pathologic and protective T-cell responses during viral infection

Biography

Biography: Joseph N Blattman

Abstract

T-cell responses have the potential for efficient protection against a wide range of virus infections. However, T-cell responses also have the potential for mediating severe pathological responses. Understanding this balance is key to the development of vaccines that maximize protection while minimizing the potential for immune-mediated pathology. As pathology arises as a consequence of the complex interplay between the dynamics of rapidly changing populations of pathogen, immune cells and the cytokines that they secrete, understanding pathology compels the joint use of animal models and mathematical modeling. We have previously described the development of quantitative mathematical models to explain the pathology observed during LCMV infection in mice, due to narrow vaccination against a single virus epitope that is most severe when intermediate numbers of naive antigen-specific CD8 T-cells are present prior to infection. We have used these models to make predictions regarding how key attributes of the T-cell response, such as cell phenotype and polyclonality affect this balance. We found, as predicted, increased pathology during LCMV infection due to an intermediate precursor frequency of memory CD8 T-cells was independent of the breadth of the memory T-cell response, but was dependent on T-cell production of TNF. In particular, abrogation of TNF signaling resulted in decreased pathology but no change in viral clearance, suggesting that TNF-blockade may be useful for minimizing pathology while maintaining protection following virus infection.